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Background
ALIX (ALG2 interacting protein X) is a multi-functional
adaptor protein that plays a central role in the regulation
of intracellular protein trafficking and apoptosis. As an
ESCRT-associated regulator of protein trafficking, ALIX
plays an essential role in retrovirus release, an activity that
is dependent on the interaction between the central V-
domain and the L-domain consensus sequence YPXnL in
Gag [1,2]. The trans-Golgi network RING finger protein
POSH (Plenty of SH3) is a scaffold protein that acts as an
E3 ligase and augments HIV-1 egress by facilitating the
transport of Gag to the cell membrane [3]. Recently, it was
reported, that POSH interacts with ALIX and thereby
enhances ALIX mediated phenotypes in Drosophila [4].
Results
In this study we identified ALIX as a POSH ubiquiti-
nation substrate in human cells: POSH induces polyubiq-
uitination of ALIX that is modified on several lysine resi-
dues in vivo and in vitro. This ubiquitination does not
destabilize ALIX, which suggests a regulatory function.
Consistent with the well known activity of ALIX in virus
release that rescues budding of L-domain mutant HIV-1
[2,5], we demonstrated that wild type POSH, but not an
ubiquitination inactive RING finger mutant (POSHV14A),
enhances ALIX mediated release of HIV-1ΔPTAP variants. In
further agreement with the idea of a cooperative function
of POSH and ALIX, mutating the YPXnL-ALIX binding site
in Gag completely abrogated augmentation of virus
release by overexpression of POSH. However, the effect of
the POSH-mediated ubiquitination appears to be auxil-
iary, but not necessary, as silencing of POSH by RNAi does
not disturb ALIX mediated augmentation of virus release.
Conclusion
Thus, the cumulative results identified ALIX as an ubiqui-
tination substrate of POSH and indicate that POSH and
ALIX cooperate to facilitate efficient virus release. How-
ever, while ALIX is obligatory for the release of YPXnL-
dependent HIV-1, POSH, albeit rate-limiting, may be
functionally interchangeable.
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